UK markets close in 5 hours 36 minutes

Oncopeptides AB (publ) (0RN4.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
35.44-0.77 (-2.12%)
As of 05:21PM BST. Market open.
Full screen
Previous close36.20
BidN/A x N/A
AskN/A x N/A
Day's range37.83 - 37.83
52-week range5.07 - 37.83
Avg. volume1,192
Market capN/A
Beta (5Y monthly)-0.37
PE ratio (TTM)N/A
Earnings date14 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

    DUBAI, United Arab Emirates and STOCKHOLM, Sweden, March 27, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO (“Vector”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in the Middle East and North Africa (“MENA”) countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq. Under the terms of this e